211 related articles for article (PubMed ID: 34187600)
1. Pathological tau drives ectopic nuclear speckle scaffold protein SRRM2 accumulation in neuron cytoplasm in Alzheimer's disease.
McMillan PJ; Strovas TJ; Baum M; Mitchell BK; Eck RJ; Hendricks N; Wheeler JM; Latimer CS; Keene CD; Kraemer BC
Acta Neuropathol Commun; 2021 Jun; 9(1):117. PubMed ID: 34187600
[TBL] [Abstract][Full Text] [Related]
2. Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
Kow RL; Strovas TJ; McMillan PJ; Jacobi AM; Behlke MA; Saxton AD; Latimer CS; Keene CD; Kraemer BC
Neurobiol Dis; 2021 Jan; 147():105148. PubMed ID: 33184027
[TBL] [Abstract][Full Text] [Related]
3. MSUT2 is a determinant of susceptibility to tau neurotoxicity.
Guthrie CR; Greenup L; Leverenz JB; Kraemer BC
Hum Mol Genet; 2011 May; 20(10):1989-99. PubMed ID: 21355046
[TBL] [Abstract][Full Text] [Related]
4. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain.
Wheeler JM; McMillan P; Strovas TJ; Liachko NF; Amlie-Wolf A; Kow RL; Klein RL; Szot P; Robinson L; Guthrie C; Saxton A; Kanaan NM; Raskind M; Peskind E; Trojanowski JQ; Lee VMY; Wang LS; Keene CD; Bird T; Schellenberg GD; Kraemer B
Sci Transl Med; 2019 Dec; 11(523):. PubMed ID: 31852801
[TBL] [Abstract][Full Text] [Related]
5. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.
Lester E; Ooi FK; Bakkar N; Ayers J; Woerman AL; Wheeler J; Bowser R; Carlson GA; Prusiner SB; Parker R
Neuron; 2021 May; 109(10):1675-1691.e9. PubMed ID: 33848474
[TBL] [Abstract][Full Text] [Related]
6. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.
Eftekharzadeh B; Daigle JG; Kapinos LE; Coyne A; Schiantarelli J; Carlomagno Y; Cook C; Miller SJ; Dujardin S; Amaral AS; Grima JC; Bennett RE; Tepper K; DeTure M; Vanderburg CR; Corjuc BT; DeVos SL; Gonzalez JA; Chew J; Vidensky S; Gage FH; Mertens J; Troncoso J; Mandelkow E; Salvatella X; Lim RYH; Petrucelli L; Wegmann S; Rothstein JD; Hyman BT
Neuron; 2018 Sep; 99(5):925-940.e7. PubMed ID: 30189209
[TBL] [Abstract][Full Text] [Related]
7. SPOP loss of function protects against tauopathy.
Eck RJ; Kow RL; Black AH; Liachko NF; Kraemer BC
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2207250120. PubMed ID: 36574656
[TBL] [Abstract][Full Text] [Related]
8. Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
McMillan PJ; Benbow SJ; Uhrich R; Saxton A; Baum M; Strovas T; Wheeler JM; Baker J; Liachko NF; Keene CD; Latimer CS; Kraemer BC
Brain; 2023 Aug; 146(8):3206-3220. PubMed ID: 36732296
[TBL] [Abstract][Full Text] [Related]
9. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
10. The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology.
Tanaka H; Kondo K; Chen X; Homma H; Tagawa K; Kerever A; Aoki S; Saito T; Saido T; Muramatsu SI; Fujita K; Okazawa H
Mol Psychiatry; 2018 Oct; 23(10):2090-2110. PubMed ID: 30283027
[TBL] [Abstract][Full Text] [Related]
11. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
[TBL] [Abstract][Full Text] [Related]
12. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
[TBL] [Abstract][Full Text] [Related]
13. SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's disease.
Younas N; Zafar S; Shafiq M; Noor A; Siegert A; Arora AS; Galkin A; Zafar A; Schmitz M; Stadelmann C; Andreoletti O; Ferrer I; Zerr I
Acta Neuropathol; 2020 Sep; 140(3):317-339. PubMed ID: 32577828
[TBL] [Abstract][Full Text] [Related]
14. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.
Kopeikina KJ; Carlson GA; Pitstick R; Ludvigson AE; Peters A; Luebke JI; Koffie RM; Frosch MP; Hyman BT; Spires-Jones TL
Am J Pathol; 2011 Oct; 179(4):2071-82. PubMed ID: 21854751
[TBL] [Abstract][Full Text] [Related]
15. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
16. SRRM2 phase separation drives assembly of nuclear speckle subcompartments.
Zhang M; Gu Z; Guo S; Sun Y; Ma S; Yang S; Guo J; Fang C; Shu L; Ge Y; Chen Z; Wang B
Cell Rep; 2024 Mar; 43(3):113827. PubMed ID: 38381607
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
18. Sut-6/NIPP1 modulates tau toxicity.
Kow RL; Black AH; Henderson BP; Kraemer BC
Hum Mol Genet; 2023 Jul; 32(14):2292-2306. PubMed ID: 37000013
[TBL] [Abstract][Full Text] [Related]
19. AβPP-tau-HAS1 axis trigger HAS1-related nuclear speckles and gene transcription in Alzheimer's disease.
Zhang YH; Sun XT; Guo RF; Feng GY; Gao HL; Zhong ML; Tian LW; Qiu ZY; Cui YW; Li JY; Zhao P
Matrix Biol; 2024 May; 129():29-43. PubMed ID: 38518923
[TBL] [Abstract][Full Text] [Related]
20. SON and SRRM2 are essential for nuclear speckle formation.
Ilik İA; Malszycki M; Lübke AK; Schade C; Meierhofer D; Aktaş T
Elife; 2020 Oct; 9():. PubMed ID: 33095160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
